Purpose: High-grade glioma (HGG) treatment is limited by the inability of otherwise potentially efficacious drugs to penetrate the blood brain barrier. We evaluate the unique intra-cavity delivery mode and translational potential of a blend of poly(DL-lactic acid-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) paste combining temozolomide and etoposide to treat surgically resected HGG. Experimental Design: To prolong stability of temozolomide pro-drug, combined in vitro drug release was quantitatively assessed from low pH-based PLGA/PEG using advanced analytical methods. In vitro cytotoxicity was measured against a panel of HGG cell lines and patient-derived cultures using metabolic assays. In vivo safety and efficacy was evaluated...
Glioblastoma (GBM) is the most common, malignant and aggressive brain tumour in adults. Despite the ...
Glioblastoma multiforme (GBM) is the most aggressive primary brain cancer in adults and unfortunatel...
To date, the clinical outcomes and survival rates for patients with glioblastoma (GB) remain poor. A...
Purpose: High-grade glioma (HGG) treatment is limited by the inability of otherwise potentially effi...
Introduction: The median survival of patients with glioblastoma multiforme (astrocytoma grade 4) rem...
Introduction: The median survival of patients with glioblastoma multiforme (astrocytoma grade 4) rem...
Thesis (S.M.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 20...
Glioblastoma is a malignant brain tumour with a median survival of 14.6 months from diagnosis. Despi...
INTRODUCTIONPolymer-based delivery systems offer innovative intra-cavity administration of drugs, wi...
Introduction Polymer-based delivery systems offer innovative intra-cavity administration of drugs, ...
Background: Chemotherapy of glioblastoma is largely ineffective as the blood-brain barrier (BBB) pre...
The treatment regimen for patients that present with glioblastoma (GBM) has improved over the years ...
Malignant brain tumor is one of the most lethal forms of cancers. In the United States alone, appro...
AbstractEffective treatment of glioblastoma multiforme remains a major clinical challenge, due in pa...
Malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) occur more frequently than ot...
Glioblastoma (GBM) is the most common, malignant and aggressive brain tumour in adults. Despite the ...
Glioblastoma multiforme (GBM) is the most aggressive primary brain cancer in adults and unfortunatel...
To date, the clinical outcomes and survival rates for patients with glioblastoma (GB) remain poor. A...
Purpose: High-grade glioma (HGG) treatment is limited by the inability of otherwise potentially effi...
Introduction: The median survival of patients with glioblastoma multiforme (astrocytoma grade 4) rem...
Introduction: The median survival of patients with glioblastoma multiforme (astrocytoma grade 4) rem...
Thesis (S.M.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 20...
Glioblastoma is a malignant brain tumour with a median survival of 14.6 months from diagnosis. Despi...
INTRODUCTIONPolymer-based delivery systems offer innovative intra-cavity administration of drugs, wi...
Introduction Polymer-based delivery systems offer innovative intra-cavity administration of drugs, ...
Background: Chemotherapy of glioblastoma is largely ineffective as the blood-brain barrier (BBB) pre...
The treatment regimen for patients that present with glioblastoma (GBM) has improved over the years ...
Malignant brain tumor is one of the most lethal forms of cancers. In the United States alone, appro...
AbstractEffective treatment of glioblastoma multiforme remains a major clinical challenge, due in pa...
Malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) occur more frequently than ot...
Glioblastoma (GBM) is the most common, malignant and aggressive brain tumour in adults. Despite the ...
Glioblastoma multiforme (GBM) is the most aggressive primary brain cancer in adults and unfortunatel...
To date, the clinical outcomes and survival rates for patients with glioblastoma (GB) remain poor. A...